23 Sep 2024
// PRESS RELEASE
23 Sep 2024
// PRESS RELEASE
31 Jan 2023
// GLOBENEWSWIRE
Data Compilation
#PharmaFlow
Latest Content by PharmaCompass
01 2CLONIDINE
02 2FENOFIBRIC ACID
03 1TRAMADOL HYDROCHLORIDE
01 1SOLUTION;ORAL
02 2TABLET, EXTENDED RELEASE;ORAL
03 2TABLET;ORAL
01 1105MG
02 135MG
03 15MG/ML
04 1EQ 0.17MG BASE
05 1EQ 0.26MG BASE
01 4DISCN
02 1RX
RLD : No
TE Code :
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Proprietary Name : NEXICLON XR
Dosage Strength : EQ 0.17MG BASE
Approval Date : 2009-12-03
Application Number : 22500
RX/OTC/DISCN : RX
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Proprietary Name : NEXICLON XR
Dosage Strength : EQ 0.26MG BASE
Approval Date : 2009-12-03
Application Number : 22500
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : FIBRICOR
Dosage Strength : 35MG
Approval Date : 2009-08-14
Application Number : 22418
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : FIBRICOR
Dosage Strength : 105MG
Approval Date : 2009-08-14
Application Number : 22418
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : SOLUTION; ORAL
Proprietary Name : QDOLO
Dosage Strength : 5MG/ML
Approval Date : 2020-09-01
Application Number : 214044
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
LOOKING FOR A SUPPLIER?
KEY PRODUCTS
Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
